Sunbelt Securities, Inc. Akebia Therapeutics, Inc. Transaction History

Sunbelt Securities, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 03, 2022	BUY	$0.32 - $0.67 $784 - $1,641	2,450 Added 21.21%	14,000 $5,000
Q4 2021 Feb 14, 2022	BUY	$2.26 - $3.34 $26,102 - $38,577	11,550 New	11,550 $21,000
Q2 2021 Jul 29, 2021	SELL	$2.83 - $4.2 $112,096 - $166,362	-39,610 Closed	0 $0
Q1 2021 May 27, 2021	BUY	$2.92 - $5.06 $115,661 - $200,426	39,610 New	39,610 $134,000

120

54.9M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $417M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Sunbelt Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on Sunbelt Securities, Inc. with notifications on news.